Laboratory of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare, 60 Nakaorui-machi, Takasaki-shi, Gunma 370-0033, Japan.
Laboratory of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare, 60 Nakaorui-machi, Takasaki-shi, Gunma 370-0033, Japan; Laboratory of Drug Delivery System, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotouge-cho, Hirakata, Osaka 573-0101, Japan.
J Pharm Sci. 2020 Jul;109(7):2302-2308. doi: 10.1016/j.xphs.2020.03.008. Epub 2020 Mar 13.
Epithelial-mesenchymal transition (EMT) plays a role in not only cancer metastasis, but also drug resistance, which is associated with increased levels of efflux transporters such as P-glycoprotein (P-gp). Here, we examined whether P-gp activation during Snail-induced EMT of lung cancer cells is mediated by ezrin, radixin, and moesin (ERM), which regulate transporter localization. HCC827 lung cancer cells overexpressing the transcription factor Snail showed increased Rhodamine123 efflux and increased paclitaxel resistance, reflecting increased P-gp activity. Concomitantly, the expression level of moesin, but not ezrin or radixin, was significantly increased. The increase of P-gp activity was suppressed by knockdown of moesin. Thus, the increase of P-gp activity associated with Snail-induced EMT may be mediated mainly by moesin in HCC827 cells. On the other hand, the Snail mRNA expression level was correlated with the expression level of each ERM in 4 non-small-cell lung cancer cell lines (HCC827, A549, H441, H1975) and in tumor tissues, but not normal tissues, of patients with lung cancer. These results suggest that P-gp activation during EMT is at least partially due to increased expression of moesin. Coadministration of moesin inhibitors with anticancer drugs might block P-gp-mediated drug efflux organ-specifically, improving treatment efficacy and minimizing side effects on other organs.
上皮-间充质转化(EMT)不仅在癌症转移中起作用,而且与药物耐药性有关,这与外排转运体如 P-糖蛋白(P-gp)的水平升高有关。在这里,我们研究了 Snail 诱导的肺癌细胞 EMT 过程中 P-gp 的激活是否是由 ezrin、radixin 和 moesin(ERM)介导的,ERM 调节转运体的定位。过表达转录因子 Snail 的 HCC827 肺癌细胞表现出 Rhodamine123 外排增加和紫杉醇耐药性增加,反映出 P-gp 活性增加。同时,moesin 的表达水平显著增加,而 ezrin 或 radixin 的表达水平没有增加。moesin 的敲低抑制了 P-gp 活性的增加。因此,与 Snail 诱导的 EMT 相关的 P-gp 活性的增加可能主要通过 HCC827 细胞中的 moesin 介导。另一方面,Snail mRNA 表达水平与 4 种非小细胞肺癌细胞系(HCC827、A549、H441、H1975)和肺癌患者肿瘤组织中的每个 ERM 的表达水平相关,但与正常组织不相关。这些结果表明,EMT 过程中 P-gp 的激活至少部分是由于 moesin 表达增加所致。与抗癌药物联合使用 moesin 抑制剂可能会特异性地阻断 P-gp 介导的药物外排,从而提高治疗效果并最小化对其他器官的副作用。